# DUKE Robotics Corp.: overview DUKR · Nasdaq · CIK 1638911 · [Industrials](/sectors/industrials.md) · fiscal year ends Dec 31 Pages: [Overview](/companies/dukr.md) · [Financials](/companies/dukr/financials.md) · [Filings](/companies/dukr/filings.md) · [Insiders](/companies/dukr/insiders.md) Latest reported revenue: [$149.0k](/filings/0001213900-26-088727.md) for Q2 FY2026, three months to 2026-06-30, from the 10-Q filed Aug 13, 2026 (XBRL us-gaap:Revenues, accession 0001213900-26-088727). ## Last eight quarters | Line item | Unit | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Revenue | $k | [72.0](/filings/0001213900-25-110845.md) | [36.0 d](/filings/0001213900-26-026927.md) | not reported | [143](/filings/0001213900-26-088727.md) | [216](/filings/0001213900-25-110845.md) | [18.0 d](/filings/0001213900-26-026927.md) | not reported | [149](/filings/0001213900-26-088727.md) | | Gross margin | % | [43.1%](/filings/0001213900-25-110845.md) | [16.7% d](/filings/0001213900-26-026927.md) | not reported | [61.5%](/filings/0001213900-26-088727.md) | [56.9%](/filings/0001213900-25-110845.md) | [(133.3%) d](/filings/0001213900-26-026927.md) | not reported | [38.9%](/filings/0001213900-26-088727.md) | | Operating margin | % | [(302.8%)](/filings/0001213900-25-110845.md) | [(786.1%) d](/filings/0001213900-26-026927.md) | not reported | [(174.8%)](/filings/0001213900-26-088727.md) | [(98.6%)](/filings/0001213900-25-110845.md) | [(2527.8%) d](/filings/0001213900-26-026927.md) | not reported | [(622.8%)](/filings/0001213900-26-088727.md) | | Net margin | % | [(293.1%)](/filings/0001213900-25-110845.md) | [(797.2%) d](/filings/0001213900-26-026927.md) | not reported | [(188.1%)](/filings/0001213900-26-088727.md) | [(106.5%)](/filings/0001213900-25-110845.md) | [(2572.2%) d](/filings/0001213900-26-026927.md) | not reported | [(487.2%)](/filings/0001213900-26-088727.md) | | Diluted EPS | $ per share | [0.00](/filings/0001213900-25-110845.md) | not reported | [(0.13)](/filings/0001213900-26-059275.md) | [(0.12)](/filings/0001213900-26-088727.md) | [0.00](/filings/0001213900-25-110845.md) | not reported | [(0.41)](/filings/0001213900-26-059275.md) | [(0.26)](/filings/0001213900-26-088727.md) | | Free cash flow | $k | not reported | [(180) d](/filings/0001213900-26-026927.md) | [(243)](/filings/0001213900-26-059275.md) | [(431) d](/filings/0001213900-26-088727.md) | [(219) d](/filings/0001213900-25-110845.md) | [(123) d](/filings/0001213900-26-026927.md) | not reported | not reported | - Revenue. XBRL Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure. - Gross margin (gross profit / revenue). XBRL Gross profit: us-gaap:GrossProfit; Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure. - Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure. - Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure. - Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Derived values: 9-month figure less the 6-month figure; 12-month figure less the 9-month figure; 6-month figure less the 3-month figure. ## Last five fiscal years | Line item | Unit | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) | | --- | --- | ---: | ---: | ---: | ---: | ---: | | Revenue | $k | [500](/filings/0001213900-23-022590.md) | not reported | [300](/filings/0001213900-25-025286.md) | [108](/filings/0001213900-26-026927.md) | [377](/filings/0001213900-26-026927.md) | | Gross margin | % | [100.0%](/filings/0001213900-22-010947.md) | not reported | [9.0%](/filings/0001213900-25-025286.md) | [34.3%](/filings/0001213900-26-026927.md) | [47.5%](/filings/0001213900-26-026927.md) | | Operating margin | % | [(88.4%)](/filings/0001213900-23-022590.md) | not reported | [(267.3%)](/filings/0001213900-25-025286.md) | [(949.1%)](/filings/0001213900-26-026927.md) | [(319.9%)](/filings/0001213900-26-026927.md) | | Net margin | % | [(177.6%)](/filings/0001213900-23-022590.md) | not reported | [(242.0%)](/filings/0001213900-25-025286.md) | [(912.0%)](/filings/0001213900-26-026927.md) | [(329.2%)](/filings/0001213900-26-026927.md) | | Diluted EPS | $ per share | [(0.02)](/filings/0001213900-23-022590.md) | [(0.06)](/filings/0001213900-24-022826.md) | [(0.02)](/filings/0001213900-25-025286.md) | [(0.45)](/filings/0001213900-26-026927.md) | [(0.57)](/filings/0001213900-26-026927.md) | | Free cash flow | $k | not reported | [(707)](/filings/0001213900-24-022826.md) | [(566)](/filings/0001213900-25-025286.md) | [(995)](/filings/0001213900-26-026927.md) | [(1,016)](/filings/0001213900-26-026927.md) | - Revenue. XBRL Revenue: us-gaap:Revenues. - Gross margin (gross profit / revenue). XBRL Gross profit: us-gaap:GrossProfit; Revenue: us-gaap:Revenues. - Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:Revenues. - Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:Revenues. - Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing. ## Insider purchases and sales The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/dukr/insiders.md) None in coverage. ## Funds that report holding it From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md) | Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before | | --- | --- | ---: | ---: | --- | --- | | [CITADEL ADVISORS LLC](/funds/1423053.md) | 2026-06-30 | $679.1k | 117,901 | | New +117,901 | | [T3 Companies, LLC](/funds/2052441.md) | 2026-06-30 | $281.7k | 48,900 | | New +48,900 | | [CITADEL ADVISORS LLC](/funds/1423053.md) | 2026-06-30 | $279.6k | 216,748 | | New +216,748 | | [Weiss Asset Management LP](/funds/1357550.md) | 2026-06-30 | $244.9k | 42,516 | | New +42,516 | | [Davidson Kempner Capital Management LP](/funds/1595082.md) | 2026-06-30 | $209.8k | 36,425 | | New +36,425 | | [Davidson Kempner Capital Management LP](/funds/1595082.md) | 2026-06-30 | $125.5k | 97,302 | | New +97,302 | | [GEODE CAPITAL MANAGEMENT, LLC](/funds/1214717.md) | 2026-06-30 | $73.3k | 12,727 | | New +12,727 | | [Warberg Asset Management LLC](/funds/1597506.md) | 2026-06-30 | $61.4k | 47,625 | | New +47,625 | | [Empery Asset Management, LP](/funds/1469336.md) | 2026-06-30 | $45.1k | 35,000 | | New +35,000 | | [Weiss Asset Management LP](/funds/1357550.md) | 2026-06-30 | $41.8k | 32,382 | | New +32,382 | ## Recent filings [All 205 filings](/companies/dukr/filings.md) | Filed | Accepted | Form | What it is | Accession | | --- | --- | --- | --- | --- | | 2026-10-27 | 16:05 ET | [8-K](/filings/0001213900-26-112911.md) | 8.01 Other events | 0001213900-26-112911 | | 2026-10-22 | 16:08 ET | [DEF 14A](/filings/0001213900-26-111701.md) | Proxy statement, period 2026-12-15 | 0001213900-26-111701 | | 2026-09-17 | 08:35 ET | [8-K](/filings/0001213900-26-100765.md) | 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-26-100765 | | 2026-08-13 | 08:30 ET | [10-Q](/filings/0001213900-26-088727.md) | Quarterly report, period 2026-06-30 | 0001213900-26-088727 | | 2026-08-13 | 08:05 ET | [8-K](/filings/0001213900-26-088712.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001213900-26-088712 | | 2026-06-11 | 08:30 ET | [8-K](/filings/0001213900-26-067570.md) | 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-26-067570 | | 2026-06-02 | 13:56 ET | [SCHEDULE 13D/A](/filings/0001178913-26-003049.md) | Ownership report, active investor, amended | 0001178913-26-003049 | | 2026-05-20 | 09:02 ET | [10-Q](/filings/0001213900-26-059275.md) | Quarterly report, period 2026-03-31 | 0001213900-26-059275 | | 2026-05-20 | 08:15 ET | [8-K](/filings/0001213900-26-059258.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-26-059258 | | 2026-05-18 | 16:31 ET | [8-K](/filings/0001213900-26-058485.md) | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-26-058485 | ## Latest annual report [Form 10-K for the fiscal year ended Dec 31, 2025](/filings/0001213900-26-026927.md), filed Mar 12, 2026. ## Forecast league Q3 FY2026, the quarter ended 2026-09-30, is open for forecasts until the first results filing for it is accepted by EDGAR. Results are due by \[object Promise\]. [Forecast this quarter](/leagues/2026q3/targets/bf1587ac-2b6c-4f0c-b41f-110246d32ebd) ## About the filer - CIK: 1638911 - Tickers: DUKR, DUKRW - Exchange: Nasdaq - SIC code: 3721 Aircraft - State of incorporation: NV - Filer category: Non-accelerated filer
Smaller reporting company Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 27, 2026, 16:06 ET. No prices; not investment advice.